会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Agglomeration protein cascades, compositions and methods regarding the same
    • 聚集蛋白级联,组合物和方法相同
    • US20060257904A1
    • 2006-11-16
    • US11400808
    • 2006-04-07
    • Abraham GrossmanJames MoeSara VasanEliot Davidowitz
    • Abraham GrossmanJames MoeSara VasanEliot Davidowitz
    • C12Q1/68C07H21/04C12P21/06C12M1/34
    • C07K14/78C07K14/4711C07K2319/00C12N15/115C12N2310/16G01N2333/4709G01N2333/78G01N2800/2821
    • Described herein are compositions and methods for identifying cellular factors involved in protein agglomeration. One such factor is a nucleic acid component. Another factor is a cellular binding factor. The nucleic acid components, and methods of using them, to interact with agglomeration proteins are also disclosed herein. The nucleic acid compositions herein comprise one or more DNA or RNA molecules having affinity for at least one agglomeration protein. The nucleic acid component is a naturally or non-naturally occurring molecule with twenty or more ribonucleotide bases. For RNA, at least one nucleotide sequence portion of this RNA molecule has affinity to at least one consensus sequence present in the agglomeration RNA-binding protein. Methods disclosed herein are directed towards detecting the presence of one or more agglomeration proteins in a sample matrix using the amplibody compositions described herein. Also described herein is an in vitro system (“TRIPARTITE”), which utilizes a NA and a non-NA chaperone to analyze the amyloid disease progression and test drugs potentially useful in combating such diseases. Also described are in vivo, transgenic animal models for analyzing amyloid diseases and agents potentially useful in combating those diseases.
    • 本文描述了用于鉴定涉及蛋白质聚集的细胞因子的组合物和方法。 一个这样的因素是核酸组分。 另一个因素是细胞结合因子。 本文还公开了核酸组分及其使用方法与附聚蛋白相互作用。 本文的核酸组合物包含一种或多种对至少一种附聚蛋白具有亲和力的DNA或RNA分子。 核酸组分是具有二十个以上核糖核苷酸碱基的天然或非天然存在的分子。 对于RNA,该RNA分子的至少一个核苷酸序列部分对结合RNA结合蛋白中存在的至少一个共有序列具有亲和力。 本文公开的方法旨在使用本文所述的扩增体组合物来检测样品基质中一种或多种附聚蛋白的存在。 本文还描述了一种体外系统(“TRIPARTITE”),其利用NA和非NA伴侣来分析淀粉样蛋白病进展并测试潜在地有助于抵抗此类疾病的药物。 还描述了用于分析淀粉样蛋白病的体内转基因动物模型和可能用于对抗这些疾病的药剂。
    • 9. 发明申请
    • Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule
    • 用于制备对靶分子具有选择亲和性的核酸分子的方法,组合物和装置
    • US20050272081A1
    • 2005-12-08
    • US11135673
    • 2005-05-24
    • Abraham Grossman
    • Abraham Grossman
    • C12M1/34C12N15/10C12P19/34C12Q1/68
    • C12N15/1058
    • The present invention is directed to methods, compositions, kits and devices for making a nucleic acid having selected affinity to a target molecule. One embodiment of the present invention is a method of making a replicatable nucleic acid template having a selected affinity to a target. The method comprises the step of applying a selection to a first generation comprising at least one replicatable nucleic acid template as the replicatable nucleic acid template is replicated by a nucleic acid polymerase to form at least one subsequent generation comprising a replicatable nucleic acid template. The selection is based on the affinity of the replicatable nucleic template of different generations to the target. The nucleic acid polymerase introduces genetic variability between generations of the replicatable nucleic acid template to produce replicatable nucleic acid templates having different affinities to the target. The replicatable nucleic acid templates are separated on the basis of the affinity of the replicatable nucleic acid template to the target.
    • 本发明涉及用于制备对靶分子具有选择亲和性的核酸的方法,组合物,试剂盒和装置。 本发明的一个实施方案是制备具有对靶的亲和力的可复制核酸模板的方法。 该方法包括将选择应用于包含至少一个可复制核酸模板的第一代,因为可复制核酸模板由核酸聚合酶复制以形成至少一个包含可复制核酸模板的后续生物。 该选择基于不同世代的可复制核酸模板对靶标的亲和力。 核酸聚合酶在可复制的核酸模板的世代之间引入遗传变异性以产生与靶具有不同亲和力的可复制的核酸模板。 可复制的核酸模板基于可重复核酸模板与靶标的亲和力而分离。